19/01/2013 00:27:00

Johnson & Johnson in Talks for Hip Implant Settlement -Bloomberg

Related content

Johnson & Johnson (JNJ) is in talks to settle litigation over recalled hip implants, Bloomberg News reported Friday, citing five people familiar with the matter.

The settlement could total more than $2 billion if most plaintiffs accept the terms, Bloomberg reported.

According to the report, J&J has offered to pay more than $200,000 per case, while lawyers for plaintiffs have said the offer is too low.

Full story at http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

January 18, 2013 19:27 ET (00:27 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Ashland Inc. enters into approximately $270 million share repurchase agreements
2
Flowserve Issues Initial Adjusted EPS Guidance for 2015 of $3.60-$4.00 and Previews Expected 2014 Key Financial Metrics
3
Novartis announces study in NEJM showing Jakavi® was superior to standard therapy in rare blood cancer polycythemia vera
4
ÅR Packaging Group AB releases additional information related to acquisition announced January 22, 2014
5
CNOVA N.V.: Strong Cash Generation of € 203 million in FY14; Net Cash position of € 534 million at year-end, or € 1.21/share; Adj. Operating Profit[1] of € 35 million in 4Q14 (+34.5% vs. 4Q13), € ...

Related stock quotes

Johnson & Johnson 101.81 0.3% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Related companies
Get access to information and recommendations of related companies with our PLUS package.

You get access to 7 valuable investment tools.

Click here to read more about the PLUS package.

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
29 January 2015 20:20:27
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150128.1 - EUROWEB4 - 2015-01-29 21:20:27 - 2015-01-29 20:20:27 - 1000 - Website: OKAY